Abstract
In the Dosing IntraVenous Administration (DIVA) study, IV ibandronate injections (15-30 s duration) provided significantly greater gains in bone mineral density than daily oral ibandronate (P
Original language | English (US) |
---|---|
Pages (from-to) | 660-665 |
Number of pages | 6 |
Journal | Bone |
Volume | 46 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2010 |
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Physiology
- Histology